| 2023/02/03 17:56:31 | |
|---|---|
| Price | |
| 73.105 USD | |
| Difference | 0.46% (0.34) |
General attributes
| ISIN | US1101221083 |
| Symbol | BMY |
| Exchange | NYSE |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 141,886 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 73.10 USD (300) |
| Ask (Ask size) | 73.11 USD (300) |
| Open | 73.21 USD |
| High | 73.68 USD |
| Low | 72.61 USD |
| Close (prev. day) | 72.77 USD |
| VWAP | 73.232513 USD |
| Volume (pcs) | 3,569,157 |
| Trading volume | 261,378,962.60 |
| Number of trades | 35,885 |
| Last size | 100 |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: BRISTOL-MYERS SQUIBB CO. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2023/01/30 |
|
Global Equity Ratings |
|
| 2023/01/09 |
|
Global Equity Ratings |
|
| 2022/12/19 |
|
Global Equity Ratings |
|
| 2022/11/28 |
|
Global Equity Ratings |
|
| 2022/11/18 |
|
Global Equity Ratings |
|
| 2023/02/03 17:56:31 | |
|---|---|
| Price | |
| 73.105 USD | |
| Difference | 0.46% (0.34) |
General attributes
| ISIN | US1101221083 |
| Symbol | BMY |
| Exchange | NYSE |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 141,886 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 73.10 USD (300) |
| Ask (Ask size) | 73.11 USD (300) |
| Open | 73.21 USD |
| High | 73.68 USD |
| Low | 72.61 USD |
| Close (prev. day) | 72.77 USD |
| VWAP | 73.232513 USD |
| Volume (pcs) | 3,569,157 |
| Trading volume | 261,378,962.60 |
| Number of trades | 35,885 |
| Last size | 100 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -7.51% | +16.31% | +17.46% |
| Perf (abs.) | -5.41 | +9.35 | +9.91 |
| Beta | 0.27 | 0.29 | 0.49 |
| Volatility | 23.88 | 21.44 | 24.21 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 72.226 USD (9,489,120) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 72.503 USD (8,113,432) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 74.080 USD (9,383,092) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 73.614 USD (11,647,360) |
| YTD High | date | 75.000 USD (2023/01/24) |
| YTD Low | date | 69.800 USD (2023/02/02) |
| 52 Weeks High | date | 81.435 USD (2022/12/01) |
| 52 Weeks Low | date | 62.900 USD (2022/02/04) |
All listings for BRISTOL-MYERS SQUIBB CO.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2023/02/03 | 17:35 | 67.63 EUR | 0.02 | 12 |
| Vienna Stock Exchange | 2023/02/03 | 17:32 | 67.75 EUR | 0.00 | 2 |
| Tradegate | 2023/02/03 | 17:50 | 67.57 EUR | 0.04 | 18 |
| Stuttgart | 2023/02/03 | 09:48 | 67.09 EUR | 0.00 | 2 |
| SIX Swiss Exchange | 2019/06/28 | 17:35 | 44.39 CHF | 0.00 | 1 |
| SIX Swiss Exchange | 2019/07/03 | 05:55 | 45.30 USD | 0.00 | 1 |
| NYSE | 2023/02/03 | 17:56 | 73.105 USD | 261.38 | 35,885 |
| Munich | 2023/02/03 | 08:01 | 66.28 EUR | 0.00 | 1 |
| London Stock Exchange European Trade Reporting | 2023/02/03 | 17:30 | 72.62 USD | 0.02 | 5 |
| Hanover | 2023/02/03 | 08:01 | 66.25 EUR | 0.00 | 1 |
| Hamburg | 2023/02/03 | 08:00 | 66.25 EUR | 0.00 | 1 |
| Frankfurt | 2023/02/03 | 16:01 | 67.08 EUR | 0.03 | 3 |
| Duesseldorf | 2023/02/03 | 17:30 | 67.56 EUR | 0.00 | 10 |
| Berlin | 2023/02/03 | 08:01 | 66.30 EUR | 0.00 | 1 |
| BX Swiss | - | - | - | 0.00 | - |
Company Logo
Contact Details
| BRISTOL MYERS SQUIBB CO. |
| - - |
| 430 East 29th Street - 10016 New York |
| Telefon: 1-212-546-4000 |
| Fax: - |
| E-mail: - |
PDF Downloads
| Company report: BRISTOL-MYERS SQUIBB CO. | |
Company Profile
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY. |
Members of Management Board
| Deepak Bhatt | Member of Board of Directors |
| Julia Haller | Member of Board of Directors |
| Karen Vousden | Member of Board of Directors |
| Manuel Hidalgo Medina | Member of Board of Directors |
| Derica Rice | Member of Board of Directors |
| Gerald Storch | Member of Board of Directors |
| Paula Price | Member of Board of Directors |
| Peter Arduini | Member of Board of Directors |
| Phyllis Yale | Member of Board of Directors |
| Theodore Samuels | Member of Board of Directors |
| Giovanni Caforio | Chairman of Managing Board |
| Christopher Boerner | Member of Executive Committee |
| Krisztina Nemenyi | Member of Executive Committee |
| Rupert Vessey | Member of Executive Committee |
| Samit Hirawat | Member of Executive Committee |
| Teresa Foy | Member of Executive Committee |
| Ann Powell | Member of Executive Committee |
| Cari Gallman | Member of Executive Committee |
| Catalina Vargas | Member of Executive Committee |
| Cynthia Piccirillo | Member of Executive Committee |
| David Elkins | Member of Executive Committee |
| Elizabeth Mily | Member of Executive Committee |
| Estelle Vester-Blokland | Member of Executive Committee |
| Frank Incontrera | Member of Executive Committee |
| Greg Meyers | Member of Executive Committee |